• Investing Ideas
  • /
  • Hong Kong Pharmaceuticals & Biotech High Growth Potential Companies
Header cover image

Hong Kong Pharmaceuticals & Biotech High Growth Potential Companies

Companies with a Future performance score of at least 3, ordered by Future performance score.

23 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
9926AkesoHK$52.95-8.8%71.6%HK$43.3bHK$72.50P/S601.2xE70.8%n/a
460Sihuan Pharmaceutical Holdings GroupHK$2.82-2.8%252.5%HK$27.6bHK$3.34P/E43.7xE45.7%1.9%
2005SSY GroupHK$5.53-14.5%9.1%HK$18.2bHK$5.96P/E27.4xE29.1%1.8%
2096Simcere Pharmaceutical GroupHK$11.14-10.9%n/aHK$30.7bHK$13.51P/E33.2xE29.2%1.6%
2696Shanghai Henlius BiotechHK$34.75-0.7%-38.4%HK$18.8bHK$64.71P/S26.1xE82.0%n/a
1873Viva Biotech HoldingsHK$8.30-1.8%-7.2%HK$17.1bHK$10.39P/S15.6xE23.8%0.3%
1801Innovent BiologicsHK$84.10-4.2%68.0%HK$124.2bHK$104.98P/S24.7xE54.3%n/a
9969InnoCare PharmaHK$27.90-8.2%94.0%HK$41.8bHK$25.01P/S16489.6xE39.4%n/a
1877Shanghai Junshi BiosciencesHK$56.35-6.4%17.4%HK$64.1bHK$94.41P/S13xE31.5%n/a
6826Shanghai Haohai Biological TechnologyHK$98.00-8.8%78.8%HK$42.2bHK$127.34P/E41xE25.3%0.6%
3692Hansoh Pharmaceutical GroupHK$29.15-9.2%-19.0%HK$175.9bHK$44.54P/E55.5xE19.9%0.3%
2269WuXi Biologics (Cayman)HK$129.70-7.3%168.0%HK$567.1bHK$148.02P/E252.8xE27.3%n/a
9939Kintor PharmaceuticalHK$78.4012.0%417.2%HK$30.4bHK$68.62P/B16xE75.3%n/a
6185CanSino BiologicsHK$290.40-7.8%35.1%HK$117.9bHK$428.59P/S114.9xE22.9%n/a
2552Hua Medicine (Shanghai)HK$4.491.1%-34.5%HK$4.3bHK$11.41P/S410.2xE68.9%n/a
6978Immunotech BiopharmHK$17.02-13.9%45.2%HK$8.8bHK$20.00P/B6.5xE95.2%n/a
1521Frontage HoldingsHK$6.98-8.9%61.2%HK$14.5bHK$6.73P/E105.4xE24.0%n/a
2877China Shineway Pharmaceutical GroupHK$8.81-4.0%74.1%HK$6.9bHK$9.74P/E18.8xE21.4%4.4%
1681Consun Pharmaceutical GroupHK$4.84-3.8%61.3%HK$4.0bHK$8.03P/E6.6xE12.1%5.7%
1558YiChang HEC ChangJiang PharmaceuticalHK$7.04-3.6%-46.8%HK$6.2bHK$12.09P/E6.2xE4.0%0%
1875TOT BIOPHARM InternationalHK$4.311.2%-12.9%HK$2.6bHK$7.39P/S91.2xS33.3%n/a
9995RemeGenHK$95.55-10.8%n/aHK$46.8bHK$130.89P/B10.8xE50.3%n/a
6600SciClone Pharmaceuticals (Holdings)HK$13.56-6.5%n/aHK$9.3bHK$20.59P/E8.2xE7.4%n/a
Page 1 of 1